Congratulations to Bart Loeys on Receiving Doctor Honoris Causa!
Bart Loeys, Professor at University of Antwerp shared on LinkedIn:
”Honored and humbled to receive the Doctor Honoris Causa from the University of Barcelona, alongside my esteemed colleague and friend, Professor Hal Dietz.
This recognition is not just about scientific achievements—it’s about the patients and families who inspire us with their courage every day.
Beyond the discoveries, this journey has been about collaboration, mentorship, and lifelong friendships.
Hal has become more than a colleague; he’s a friend for life, and I deeply value the path we’ve traveled together.
A heartfelt thank you to the young researchers, lab technicians, PhD students, and postdocs whose dedication and hard work have made this possible.
This honor is shared with all of you.”
More winner stories featured in Hemostasis Today.
-
Sep 8, 2025, 07:48Andreas Zirlik Announces EAS Rare Lipid Disorders Course at 7th Cardio Summit Graz
-
Sep 8, 2025, 06:22Noa Kabera Joins EAHAD as Project Coordinator to Advance Haemophilia and Allied Disorders Care
-
Sep 7, 2025, 16:14Paddy Barret on Thin Cap Fibroatheroma's Outcomes
-
Sep 7, 2025, 14:17Edina Cenko Shares Lancet Regional Health Series on Inequalities in Cardiovascular Care
-
Sep 7, 2025, 14:04Pedal Circulation Status Found Crucial for Wound Healing in Chronic Limb-Threatening Ischemia
-
Sep 8, 2025, 14:22GLP-1 Receptor Agonists and Cardiovascular Benefits․ Role of Clinical Features
-
Sep 8, 2025, 14:21Hamza A. Salim: CTA Collateral Impairment Score Enhances Stroke Prognosis Accuracy
-
Sep 7, 2025, 17:19Tessa Jaspers and Colleagues on Current Evidence Not Supporting Routine Anti-Xa Monitoring in Use of LMWH
-
Sep 7, 2025, 14:11New RPTH Journal Research: Statins Reduce Thrombosis Risk but Not Severity of Pulmonary Embolism
-
Sep 7, 2025, 13:37Unfractionated Heparin Dosing in ECMO: A Systematic Review and Meta-Analysis
-
Sep 8, 2025, 14:24Von Willebrand Factor as a Therapeutic Target․ From Development to Clinical Application
-
Sep 7, 2025, 14:16Mary Kiige: Biological Hemoglobin Oxygen Carrier as a Lifesaving Oxygen Bridge
-
Sep 7, 2025, 14:13Breakthrough in Blood: Cécile Denis and INSERM Team Develop Nanobody Therapy for Type 1 VWD
-
Sep 2, 2025, 13:53Cost-Effective Strategies to Reduce Anaemia Highlighted in The Lancet Haematology
-
Sep 2, 2025, 13:04Ischemic Stroke or TIA Linked to Higher Femoral Fracture Risk
-
Sep 8, 2025, 15:10Michael Makris on WHO’s Essential Medicines List Update: A Win for the Global Haemophilia Community
-
Sep 8, 2025, 14:26European Haemophilia Consortium Marks World PT Day: Physiotherapy Empowers People with Bleeding Disorders
-
Sep 8, 2025, 07:03Omar Adwan Explains the Key Difference Between Serum and Plasma
-
Sep 8, 2025, 05:27Kerry Bozza Funkhouser at BIC 2025 Roundtable on Heavy Menstrual Bleeding and Rare Bleeding Disorders
-
Sep 7, 2025, 17:30Louise Bannon Invites You To Join The ''Blood Clot Busters'' Series Uncovering The Truth About Thrombosis